Abbott Laboratories to Pay Nearly $1 Million to Oregon in Baby Formula Settlement
Abbott Laboratories will pay nearly $1 million to Oregon as part of a larger settlement concerning the sale of baby formula under unsafe conditions.
Portland, OR, September 14, 2026 — Abbott Laboratories has agreed to pay nearly $1 million to the state of Oregon. This payment is part of a broader settlement related to the sale of baby formula under conditions deemed unsafe.
The agreement involves a payment of approximately $1 million that will be remitted to Oregon. Details regarding the specific nature of the “unsafe conditions” under which the baby formula was sold were not provided in the summary information. The exact timeline for this payment or the full scope of the larger settlement involving Abbott Laboratories and other entities was also not specified.
This development follows concerns raised about the manufacturing and distribution practices of certain infant formula products. The funds allocated to Oregon are part of a resolution to address these issues. Abbott Laboratories is a major manufacturer of infant formula, among other health products.
The settlement aims to resolve legal claims concerning past practices. The company’s commitment to pay this sum to Oregon signifies a step towards addressing the allegations. Further details about the total amount of the larger settlement and how other participating states or entities are affected were not made available in the provided summary.
Story summarized from the original created by Rose Hinchliff on www.koin.com, see more information here.
